Operating Income for Eli Lilly (LLY)
According to Eli Lilly's latest reported financial statements, the company's current operating income (TTM) is $29.70B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
LLY
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$29.70B
YoY change
+69.7%
5Y CAGR
+32.7%
Peak year (2025)
$29.70B
Cumulative operating income
$198.75B
Operating Income history chart for Eli Lilly (LLY) from 1985 to 2025
Operating Income history table for Eli Lilly (LLY) from 1985 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $29.70B | +69.7% | ||
| 2024 | $17.50B | +62.2% | ||
| 2023 | $10.79B | +24.7% | ||
| 2022 | $8.65B | +9.1% | ||
| 2021 | $7.93B | +10.0% | ||
| 2020 | $7.21B | +20.2% | ||
| 2019 | $6.00B | -0.4% | ||
| 2018 | $6.03B | +41.8% | ||
| 2017 | $4.25B | +9.8% | ||
| 2016 | $3.87B | +7.8% | ||
| 2015 | $3.59B | +7.9% | ||
| 2014 | $3.33B | -40.0% | ||
| 2013 | $5.55B | +10.6% | ||
| 2012 | $5.02B | -20.6% | ||
| 2011 | $6.32B | -6.7% | ||
| 2010 | $6.77B | +6.3% | ||
| 2009 | $6.37B | +15.2% | ||
| 2008 | $5.53B | +15.1% | ||
| 2007 | $4.80B | +16.4% | ||
| 2006 | $4.13B | +13.1% | ||
| 2005 | $3.65B | -0.3% | ||
| 2004 | $3.66B | +4.5% | ||
| 2003 | $3.50B | +5.2% | ||
| 2002 | $3.33B | -10.8% | ||
| 2001 | $3.73B | +4.8% | ||
| 2000 | $3.56B | +5.8% | ||
| 1999 | $3.36B | +19.1% | ||
| 1998 | $2.82B | +15.8% | ||
| 1997 | $2.44B | +19.3% | ||
| 1996 | $2.04B | +3.2% | ||
| 1995 | $1.98B | +10.4% | ||
| 1994 | $1.79B | +175.0% | ||
| 1993 | $652.60M | -43.5% | ||
| 1992 | $1.16B | -34.7% | ||
| 1991 | $1.77B | +14.9% | ||
| 1990 | $1.54B | +32.2% | ||
| 1989 | $1.16B | +11.3% | ||
| 1988 | $1.05B | +75.9% | ||
| 1987 | $595.00M | -30.8% | ||
| 1986 | $860.30M | +12.5% | ||
| 1985 | $764.40M | — |
Operating Income values are taken from Eli Lilly's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual operating income for Eli Lilly (LLY) came in at $29.70B – surged 69.7% year-over-year.
Through 2020–2025 (5 years), Eli Lilly operating income delivered a +32.7% annualised rate; sustaining 6 straight years of year-over-year growth.
2025 marks the peak operating income at $29.70B, with the historical low of $595.00M recorded in 1987.
Among 8 Healthcare peers, Eli Lilly (LLY) ranks 2nd; the peer median for operating income is $19.53B.
Eli Lilly Operating Income by Year
Eli Lilly Operating Income 2025: $29.70B
Eli Lilly operating income in 2025 was $29.70B, surged 69.7% from 2024. This figure represents the highest annual value in the available history.
Eli Lilly Operating Income 2024: $17.50B
Eli Lilly operating income in 2024 was $17.50B, surged 62.2% from 2023.
Eli Lilly Operating Income 2023: $10.79B
Eli Lilly operating income in 2023 was $10.79B, grew 24.7% from 2022.
Eli Lilly Operating Income 2022: $8.65B
Eli Lilly operating income in 2022 was $8.65B, grew 9.1% from 2021.
Eli Lilly Operating Income 2021: $7.93B
Eli Lilly operating income in 2021 was $7.93B.
See more financial history for Eli Lilly (LLY).
Sector peers — Operating Income
Companies in the same sector as Eli Lilly, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $8.11B | Healthcare |
Frequently asked questions
What is Eli Lilly's operating income?
- Latest reported operating income for Eli Lilly (LLY) is $29.70B (period ending December 31, 2025).
How has Eli Lilly operating income changed year-over-year?
- Eli Lilly (LLY) operating income changed +69.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Eli Lilly operating income?
- Eli Lilly (LLY) operating income compound annual growth rate is +32.7% over the most recent 5 years available.
When did Eli Lilly operating income hit its highest annual value?
- Eli Lilly operating income reached its highest annual value of $29.70B in 2025.
What was Eli Lilly operating income in 2024?
- Eli Lilly (LLY) operating income in 2024 was $17.50B.
What was Eli Lilly operating income in 2025?
- Eli Lilly (LLY) operating income in 2025 was $29.70B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
LLY Overview
Company profile, financial tools, and key metrics
LLY Revenue Counter
Earns $2,067 every second. See per minute, hour, and day.
LLY Earnings Counter
Earns $654.44 per second net profit. See per minute, hour, and day.
LLY Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
LLY What If Invested
What if you had invested $1,000? See historical returns from any date.
LLY How It Makes Money
Discover visual breakdown of $65.18B in revenue — where it comes from and where it goes.
LLY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
LLY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
LLY Daily Price Character
Steady · 48.0% historical win rate (green days). Streaks & record days.
LLY Buybacks
0.43% TTM buyback yield. Shareholder yield & SBC comparison.
LLY Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
LLY Dividend Profile
Yield: 0.73%. Safety: 8/8. See full history.
LLY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
LLY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.